4.7 Review

Childhood B-Cell Preleukemia Mouse Modeling

Related references

Note: Only part of the references are listed.
Article Oncology

Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

Ana Casado-Garcia et al.

Summary: This study demonstrates that early-life administration of the JAK1/2 inhibitor ruxolitinib significantly reduces the risk of B-ALL in mice. This finding presents a potential strategy for preventing the development of B-ALL.

CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

The PAX5-JAK2 translocation acts as dual-hit mutation that promotes aggressive B-cell leukemia via nuclear STAT5 activation

Sabine Jurado et al.

Summary: PAX5 is an important tumor suppressor gene in B-cell acute lymphoblastic leukemia, but it is also involved in coding for various PAX5 fusion proteins. A study found that the PAX5-JAK2 fusion protein can promote leukemia development in a mouse model.

EMBO JOURNAL (2022)

Article Multidisciplinary Sciences

An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia

Ifat Geron et al.

Summary: This study reveals that activating mutations in Interleukin-7 receptor alpha can initiate preleukemia in primary human hematopoietic progenitors and cooperate with CDKN2A silencing in the progression into acute lymphoblastic leukemia (BCP-ALL).

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

Dennis Das Gupta et al.

Summary: This study finds that Irf4(-/-) mice are prone to developing BCP-ALL, and further investigates the impaired differentiation but enhanced proliferation of Irf4(-/-) preB-I cells, possibly due to Jak3 mutations.

CELL DEATH AND DIFFERENTIATION (2022)

Article Oncology

Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice

Kerri R. Thomas et al.

Summary: Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a high-risk subtype of B-ALL often associated with genetic variants altering cytokine receptor signaling, such as mutations in the interleukin-7 receptor (IL7R). Mouse models expressing activated Il7r (aIL7R) demonstrated that Il7r activating mutations are sufficient for leukemogenesis, with additional mutations in associated adapter protein Lnk or transcription factor Ikaros increasing disease penetrance. Phosphoproteomic analyses revealed constitutive Stat5 and BCR-like signaling in aIL7R leukemic cells, and inhibition of Jak, mTOR, or Syk pathways blocked growth in vitro.

LEUKEMIA (2022)

Article Multidisciplinary Sciences

Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia

Afonso R. M. Almeida et al.

Summary: The study shows that activating mutations in IL7Ra can initiate precursor B-cell acute lymphoblastic leukemia, and the mechanism is elucidated through research on a knock-in mouse model, providing new directions for the treatment of this type of leukemia.

NATURE COMMUNICATIONS (2021)

Editorial Material Immunology

An immune window of opportunity to prevent childhood B cell leukemiai

Cesar Cobaleda et al.

Summary: The prevalence of childhood B-ALL is increasing, particularly in developed countries, with immune system stress potentially playing a significant role besides genetic predisposition. The implications of this knowledge for B-ALL prevention strategies need to be further explored.

TRENDS IN IMMUNOLOGY (2021)

Article Cell Biology

The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia

Guillermo Rodriguez-Hernandez et al.

Summary: ETV6-RUNX1 is closely associated with childhood B-cell acute lymphoblastic leukemia (B-ALL), but its impact on cell lineage decisions during B-cell leukemia development is unclear. The study reveals that the second hit from ETV6-RUNX1 determines tumor cell identity, and both oncogenic hits must occur early in the development of hematopoietic/precursor cells. Depending on the nature of the second hit, distinct entities of B-ALL with separable gene expression profiles are presented.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Immunology

Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia

Cesar Cobaleda et al.

Summary: B cell acute lymphoblastic leukaemia (B-ALL) is the most common form of childhood cancer, but treatment still fails in a significant percentage of patients. Studies have shown that a small percentage of healthy newborns carry preleukaemic clones, but only a small proportion of them will progress to overt leukemia.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Cell Biology

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia

Javier Raboso-Gallego et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Review Immunology

Flip the coin: IL-7 and IL-7R in health and disease

Joao T. Barata et al.

NATURE IMMUNOLOGY (2019)

Article Genetics & Heredity

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

Zhaohui Gu et al.

NATURE GENETICS (2019)

Review Oncology

Somatic and germline genomics in paediatric acute lymphoblastic leukaemia

Ching-Hon Pui et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Multidisciplinary Sciences

Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID

Guillermo Rodriguez-Hernandez et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice

Laura Jamrog et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Pediatrics

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

Ching-Hon Pui et al.

LANCET CHILD & ADOLESCENT HEALTH (2018)

Review Oncology

A causal mechanism for childhood acute lymphoblastic leukaemia

Mel Greaves

NATURE REVIEWS CANCER (2018)

Article Oncology

Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases

Guillermo Rodriguez-Hernandez et al.

CANCER RESEARCH (2017)

Article Biochemistry & Molecular Biology

Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia

Leonie Smeenk et al.

EMBO JOURNAL (2017)

Article Oncology

Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5+/- leukemia

Louise van der Weyden et al.

BMC CANCER (2015)

Article Medicine, Research & Experimental

Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia

Jesus Duque-Afonso et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Editorial Material Oncology

Infection and the Perils of B-cell Activation

Mel Greaves et al.

CANCER DISCOVERY (2015)

Article Medicine, General & Internal

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

K. G. Roberts et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Education, Scientific Disciplines

The genomic landscape of acute lymphoblastic leukemia in children and young adults

Charles G. Mullighan

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)

Article Immunology

Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia

Lynn M. Heltemes-Harris et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Cell & Tissue Engineering

TEL-AML1 Corrupts Hematopoietic Stem Cells to Persist in the Bone Marrow and Initiate Leukemia

Jeffrey W. Schindler et al.

CELL STEM CELL (2009)

Article Oncology

Trends in childhood cancer incidence in the US (1992-2004)

Amy M. Linabery et al.

CANCER (2008)

Article Multidisciplinary Sciences

Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia

Dengli Hong et al.

SCIENCE (2008)

Article Multidisciplinary Sciences

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Charles G. Mullighan et al.

NATURE (2007)

Article Biochemistry & Molecular Biology

Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model

M Fischer et al.

ONCOGENE (2005)

Article Multidisciplinary Sciences

Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice

S Tsuzuki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)